|
Showing 1 - 2 of
2 matches in All Departments
Clinical Ethics at the Crossroads of Genetic and Reproductive
Technologies offers thorough discussions on preconception carrier
screening, genetic engineering and the use of CRISPR gene editing,
mitochondrial gene replacement therapy, sex selection, predictive
testing, secondary findings, embryo reduction and the moral status
of the embryo, genetic enhancement, and the sharing of genetic
data. Chapter contributions from leading bioethicists and
clinicians encourage a global, holistic perspective on applied
challenges and the moral questions relating the implementation of
genetic reproductive technology. The book is an ideal resource for
practitioners, regulators, lawmakers, clinical researchers, genetic
counselors and graduate and medical students. As the Human Genome
Project has triggered a technological revolution that has
influenced nearly every field of medicine, including reproductive
medicine, obstetrics, gynecology, andrology, prenatal genetic
testing, and gene therapy, this book presents a timely resource.
The Human Genome Project has triggered a technological revolution
that has influenced nearly every field of medicine, including
reproductive medicine, obstetrics, gynecology, andrology, prenatal
genetic testing, and gene therapy. This second edition of Clinical
Ethics at the Crossroads of Genetic and Reproductive Technologies
offers a thorough, timely discussion of ethical issues raised by
the latest genetic and genomic technologies applied in human
reproductive and prenatal medicine, providing practical
recommendations, guidelines, and algorithms to support ethical
clinical practice. Here, international experts consider the ethics
of technologies from preconception carrier screening to genetic
engineering, CRISPR gene editing, mitochondrial gene replacement
therapy, sex selection, predictive testing, secondary findings,
embryo reduction, and the moral status of the embryo, genetic
enhancement, and the sharing of genetic data. Throughout the book,
contributors adopt a global, holistic perspective on applied
challenges and the moral questions around the implementation of
genetic reproductive technologies. The book is an ideal resource
for practitioners, regulators, lawmakers, clinical researchers,
genetic counselors, and graduate and medical students.This fully
updated second edition examines new developments in the field,
tackling ethical aspects of organoid development, recent advances
in pharmacogenomics, direct-to-consumer genetic testing, and
genetic engineering.
|
|